Patent · US Active

Compounds, compositions and methods for reducing lipid levels

US8710071B2 · kind B2 · utility

0Cited by
4References
40Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 22, 2009
Grant dateApr 29, 2014
Priority date
Expiry dateSep 12, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D495/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present technology relates to compounds of Formulas (V) and methods of making and using such compounds. Methods of use include prevention and treatment of hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, and metabolic syndrome. Compounds disclosed herein also lower total cholesterol, LDL-cholesterol, and triglycerides and increase hepatic LDL receptor expression, inhibit PCSK9 expression, and activate AMP-activated protein kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.